News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257,138 Results
Type
Article (12230)
Company Profile (33)
Press Release (244872)
Multimedia
Podcasts (21)
Webinars (3)
Section
Business (76627)
Career Advice (1077)
Deals (14595)
Drug Delivery (36)
Drug Development (35407)
Employer Resources (39)
FDA (6128)
Job Trends (5870)
News (129988)
Policy (9690)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
Academia (774)
Academic (1)
Accelerated approval (17)
Adcomms (14)
Allergies (101)
Alliances (10453)
ALS (91)
Alzheimer's disease (769)
Antibody-drug conjugate (ADC) (211)
Approvals (6498)
Artificial intelligence (291)
Autoimmune disease (120)
Automation (27)
Bankruptcy (97)
Best Places to Work (5208)
BIOSECURE Act (2)
Biosimilars (125)
Biotechnology (23)
Bladder cancer (142)
Brain cancer (34)
Breast cancer (484)
Cancer (3341)
Cardiovascular disease (268)
Career advice (856)
Career pathing (11)
CAR-T (150)
CDC (13)
Cell therapy (409)
Cervical cancer (34)
Clinical research (33058)
Collaboration (960)
Company closure (1)
Compensation (1213)
Complete response letters (19)
COVID-19 (1007)
CRISPR (54)
C-suite (399)
Cystic fibrosis (74)
Data (4533)
Denatured (1)
Depression (82)
Diabetes (305)
Diagnostics (2556)
Digital health (24)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (137)
Drug pricing (58)
Drug shortages (11)
Duchenne muscular dystrophy (143)
Earnings (59369)
Editorial (19)
Employer branding (5)
Employer resources (34)
Events (42191)
Executive appointments (498)
FDA (8161)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (16)
Funding (820)
Gene editing (107)
Generative AI (17)
Gene therapy (325)
GLP-1 (558)
Government (1465)
Grass and pollen (5)
Guidances (360)
Healthcare (7401)
HIV (52)
Huntington's disease (23)
IgA nephropathy (56)
Immunology and inflammation (174)
Immuno-oncology (37)
Indications (87)
Infectious disease (1159)
Inflammatory bowel disease (111)
Inflation Reduction Act (4)
Influenza (62)
Intellectual property (90)
Interviews (194)
IPO (9325)
IRA (16)
Job creations (994)
Job search strategy (747)
JPM (19)
Kidney cancer (15)
Labor market (49)
Layoffs (194)
Leadership (14)
Legal (1742)
Liver cancer (53)
Longevity (8)
Lung cancer (473)
Lymphoma (296)
Machine learning (21)
Management (13)
Manufacturing (346)
MASH (122)
Medical device (5389)
Medtech (5418)
Mergers & acquisitions (6005)
Metabolic disorders (801)
mRNA (40)
Multiple sclerosis (104)
NASH (9)
Neurodegenerative disease (183)
Neuropsychiatric disorders (53)
Neuroscience (1498)
NextGen: Class of 2026 (2281)
Non-profit (1496)
Now hiring (19)
Obesity (367)
Opinion (88)
Ovarian cancer (95)
Pain (113)
Pancreatic cancer (129)
Parkinson's disease (164)
Partnered (9)
Patents (183)
Patient recruitment (266)
Peanut (43)
People (10365)
Pharmaceutical (12)
Pharmacy benefit managers (11)
Phase 1 (9134)
Phase 2 (14121)
Phase 3 (12511)
Pipeline (4327)
Policy (62)
Postmarket research (1268)
Preclinical (3119)
Press Release (14)
Prostate cancer (180)
Psychedelics (26)
Radiopharmaceuticals (155)
Rare diseases (516)
Real estate (1180)
Recruiting (17)
Regulatory (8861)
Reports (28)
Research institute (771)
Resumes & cover letters (199)
Rett syndrome (26)
RNA editing (7)
RSV (59)
Schizophrenia (108)
Series A (123)
Series B (105)
Service/supplier (2)
Sickle cell disease (64)
Special edition (14)
Spinal muscular atrophy (59)
Sponsored (17)
Startups (832)
State (1)
Stomach cancer (8)
Supply chain (59)
Tariffs (26)
The Weekly (20)
Vaccines (483)
Venture capital (40)
Weight loss (242)
Women's health (43)
Worklife (5)
Date
Today (85)
Last 7 days (463)
Last 30 days (1900)
Last 365 days (19080)
2026 (3257)
2025 (19424)
2024 (18407)
2023 (17837)
2022 (21574)
2021 (22719)
2020 (20351)
2019 (17974)
2018 (12803)
2017 (12137)
2016 (10412)
2015 (12724)
2014 (9078)
2013 (6615)
2012 (7212)
2011 (7510)
2010 (6715)
Location
Africa (298)
Alabama (31)
Alaska (1)
Arizona (97)
Arkansas (7)
Asia (15533)
Australia (2388)
California (7710)
Canada (1838)
China (718)
Colorado (287)
Connecticut (313)
Delaware (271)
Europe (36623)
Florida (891)
Georgia (185)
Hawaii (3)
Idaho (20)
Illinois (553)
India (37)
Indiana (300)
Iowa (12)
Japan (349)
Kansas (59)
Kentucky (22)
Louisiana (22)
Maine (41)
Maryland (783)
Massachusetts (5458)
Michigan (147)
Minnesota (346)
Mississippi (4)
Missouri (77)
Montana (15)
Nebraska (8)
Nevada (84)
New Hampshire (57)
New Jersey (1950)
New Mexico (12)
New York (1777)
North Carolina (763)
North Dakota (2)
Northern California (3853)
Ohio (186)
Oklahoma (7)
Oregon (16)
Pennsylvania (1300)
Puerto Rico (6)
Rhode Island (19)
South America (447)
South Carolina (18)
Southern California (3002)
Tennessee (88)
Texas (1090)
United States (25213)
Utah (153)
Vermont (1)
Virginia (153)
Washington D.C. (34)
Washington State (609)
West Virginia (2)
Wisconsin (98)
257,138 Results for "4".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Bonus Episode: Q3 2025 Job Market Update
In this bonus episode,
BioSpace’s
Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel take a look at Q4 job market performance and what it signals for 2026.
January 19, 2026
·
1 min read
·
Angela Gabriel
Press Releases
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
February 9, 2026
·
8 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
Rare diseases
Rare Disease Biotechs Stand To Lose $4B if Priority Voucher Program Not Reinstated: Report
Some 200 rare disease therapies are at risk of losing eligibility for a pediatric priority review voucher, a recent analysis by the Rare Disease Company Coalition shows. That could mean $4 billion in missed revenue for already cash-strapped biotechs.
January 26, 2026
·
7 min read
·
Heather McKenzie
Press Releases
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026
March 4, 2026
·
1 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026
March 4, 2026
·
1 min read
Press Releases
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 4, 2026
March 5, 2026
·
1 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026
March 4, 2026
·
1 min read
Press Releases
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026
March 4, 2026
·
2 min read
MASH
Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech
The pact between Madrigal Pharmaceuticals and Ruzhou Ribo Life Sciences could complement the former’s Rezdiffra, the first FDA-approved therapy for MASH. That drug made $287.3 million in the third quarter of 2025.
February 11, 2026
·
2 min read
·
Tristan Manalac
1 of 25,714
Next
